Muna Bhanji is a director of Intellia Therapeutics Inc.
Person profile
Roles
Address
South San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Intellia Therapeutics, Inc.
2 Nov 23
4
Intellia Therapeutics, Inc.
2 Aug 23
144
Intellia Therapeutics, Inc.
31 Jul 23
4
Intellia Therapeutics, Inc.
10 Jul 23
144
CYTOKINETICS INC
7 Jul 23
4
CYTOKINETICS INC
7 Jul 23
144
Intellia Therapeutics, Inc.
6 Jul 23
4
VERACYTE, INC.
21 Jun 23
4
ARDELYX, INC.
16 Jun 23
4
Intellia Therapeutics, Inc.
16 Jun 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Oct 23 | NTLA Intellia Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 23.9 | 265 | 6.33 k | 11,996 |
31 Jul 23 | NTLA Intellia Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 42.33 | 265 | 11.22 k | 12,261 |
16 Jun 23 | VCYT Veracyte | Common Stock | Sell | Dispose S | No | Yes | 27.09 | 100 | 2.71 k | 28,514 |
16 Jun 23 | VCYT Veracyte | Common Stock | Sell | Dispose S | No | Yes | 26.4244 | 5,793 | 153.08 k | 28,614 |
15 Jun 23 | ARDX Ardelyx | Stock Option Common Stock | Grant | Acquire A | No | No | 3.92 | 49,237 | 193.01 k | 49,237 |
14 Jun 23 | NTLA Intellia Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 4,425 | 0.00 | 14,393 |
14 Jun 23 | NTLA Intellia Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 45.2 | 6,473 | 292.58 k | 6,473 |